Drug Markets/Clorazepate Dipotassium

Clorazepate Dipotassium

29 NDCs across 5 manufacturers|29 Generic,0 Brand

Clorazepate Dipotassium is used to treat alcohol withdrawal delirium, anxiety disorders and partial epilepsies, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved Jun 23, 1987. FDA's Orange Book lists 13 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $11 million on Clorazepate Dipotassium across 131,000 claims for 24,000 beneficiaries.

Clorazepate Dipotassium is available as 29 NDCs from 5 manufacturers (29 generic, 0 brand), with NADAC prices from $0.58 to $0.90 per EAa 55% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

29

29G / 0B

Manufacturers

5

competing in market

Price Spread

$0.58 – $0.90

per EA

7d Activity

11180 flat

avg -3.9% WoW · of 29 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

29 NDCs total, 29 shown

Drug Price 7d Change
CLORAZEPATE 15 MG TABLET
$0.9004
per EA
-9.56%
CLORAZEPATE 15 MG TABLET
$0.9004
per EA
-9.56%
CLORAZEPATE 15 MG TABLET
$0.9004
per EA
-9.56%
CLORAZEPATE 15 MG TABLET
$0.9004
per EA
-9.56%
CLORAZEPATE 15 MG TABLET
$0.9004
per EA
-9.56%
CLORAZEPATE 15 MG TABLET
$0.9004
per EA
-9.56%
CLORAZEPATE 15 MG TABLET
$0.9004
per EA
-9.56%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 7.5 MG TABLET
$0.8727
per EA
+4.37%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%
CLORAZEPATE 3.75 MG TABLET
$0.5815
per EA
-8.52%

Frequently Asked Questions

What is Clorazepate Dipotassium used to treat?

Clorazepate Dipotassium is used to treat alcohol withdrawal delirium, anxiety disorders and partial epilepsies, per the National Library of Medicine's MED-RT classification.

When did Clorazepate Dipotassium become available as a generic?

FDA approved the first generic Clorazepate Dipotassium (ANDA) on Jun 23, 1987. The Orange Book currently lists 13 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Clorazepate Dipotassium?

In 2024, Medicare Part D spent $11 million on Clorazepate Dipotassium across 131,000 claims for 24,000 beneficiaries.

How many Clorazepate Dipotassium products are on the market?

The Clorazepate Dipotassium drug market contains 29 NDCs from 5 manufacturers — 29 generic and 0 brand products.

What is the price range for Clorazepate Dipotassium?

NADAC reference prices for Clorazepate Dipotassium range from $0.5815 to $0.9004 per EA — a 55% difference between cheapest and most expensive.

Which manufacturers make Clorazepate Dipotassium?

5 manufacturers list Clorazepate Dipotassium in NADAC. Ranked by number of NDCs, the largest are ANI Pharmaceuticals, Inc. (9), Aurolife Pharma LLC (9), Taro Pharmaceuticals U.S.A. Inc. (5), NorthStar Rx LLC (3), Apotex Corp. (3).

How has the price of Clorazepate Dipotassium changed recently?

Over the past 7 days, 11 Clorazepate Dipotassium NDCs rose and 18 fell, with a market-wide average change of -3.9%.